Concepts (144)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Thoracic Outlet Syndrome | 2 | 2020 | 97 | 0.670 |
Why?
|
Decompression, Surgical | 1 | 2017 | 608 | 0.410 |
Why?
|
Nerve Compression Syndromes | 1 | 2014 | 160 | 0.410 |
Why?
|
Catheterization | 1 | 2017 | 1432 | 0.400 |
Why?
|
Humerus | 1 | 2014 | 272 | 0.390 |
Why?
|
Ferric Compounds | 3 | 2008 | 378 | 0.380 |
Why?
|
Embolization, Therapeutic | 4 | 2021 | 1418 | 0.330 |
Why?
|
Yttrium Radioisotopes | 2 | 2021 | 107 | 0.320 |
Why?
|
Upper Extremity | 1 | 2014 | 657 | 0.320 |
Why?
|
Contrast Media | 7 | 2017 | 5310 | 0.320 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2015 | 1116 | 0.300 |
Why?
|
Angiography | 3 | 2020 | 1599 | 0.290 |
Why?
|
Image Enhancement | 2 | 2008 | 2884 | 0.270 |
Why?
|
Oxides | 1 | 2006 | 401 | 0.240 |
Why?
|
Liver Neoplasms | 4 | 2021 | 4321 | 0.240 |
Why?
|
Superior Vena Cava Syndrome | 1 | 2024 | 56 | 0.220 |
Why?
|
Carcinoma, Hepatocellular | 3 | 2021 | 2299 | 0.220 |
Why?
|
Vascular Patency | 1 | 2024 | 910 | 0.180 |
Why?
|
Radiation Pneumonitis | 1 | 2020 | 102 | 0.170 |
Why?
|
Radiopharmaceuticals | 2 | 2020 | 2650 | 0.170 |
Why?
|
Nanoparticles | 2 | 2008 | 1955 | 0.170 |
Why?
|
Iron | 1 | 2006 | 1792 | 0.150 |
Why?
|
Magnetic Resonance Imaging | 8 | 2014 | 36430 | 0.150 |
Why?
|
Prosthesis Design | 1 | 2024 | 2115 | 0.140 |
Why?
|
Phlebography | 1 | 2017 | 326 | 0.130 |
Why?
|
Angioplasty | 1 | 2017 | 354 | 0.120 |
Why?
|
Bacterial Proteins | 1 | 2008 | 3847 | 0.120 |
Why?
|
Salvage Therapy | 1 | 2021 | 1264 | 0.120 |
Why?
|
Palpation | 1 | 2014 | 166 | 0.110 |
Why?
|
Paresthesia | 1 | 2014 | 162 | 0.110 |
Why?
|
Shoulder Pain | 1 | 2014 | 151 | 0.100 |
Why?
|
Stents | 1 | 2024 | 3179 | 0.100 |
Why?
|
Multiple System Atrophy | 1 | 2012 | 129 | 0.090 |
Why?
|
Nanostructures | 2 | 2006 | 551 | 0.090 |
Why?
|
Fractures, Bone | 1 | 2022 | 2046 | 0.090 |
Why?
|
Liver Transplantation | 1 | 2021 | 2333 | 0.080 |
Why?
|
Thrombolytic Therapy | 1 | 2017 | 2062 | 0.080 |
Why?
|
Databases, Factual | 1 | 2024 | 7954 | 0.080 |
Why?
|
Precancerous Conditions | 1 | 2015 | 978 | 0.080 |
Why?
|
Metalloproteins | 1 | 2008 | 101 | 0.080 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2012 | 664 | 0.080 |
Why?
|
Societies, Medical | 1 | 2020 | 3905 | 0.070 |
Why?
|
Catheter Ablation | 1 | 2021 | 2752 | 0.070 |
Why?
|
Doxycycline | 1 | 2008 | 344 | 0.070 |
Why?
|
Ferrosoferric Oxide | 1 | 2006 | 348 | 0.060 |
Why?
|
Magnetite Nanoparticles | 1 | 2006 | 317 | 0.060 |
Why?
|
Dextrans | 1 | 2006 | 573 | 0.060 |
Why?
|
Genes, Bacterial | 1 | 2008 | 1079 | 0.060 |
Why?
|
Molecular Imaging | 1 | 2011 | 815 | 0.060 |
Why?
|
Treatment Outcome | 6 | 2024 | 64645 | 0.060 |
Why?
|
Pain Measurement | 1 | 2014 | 3552 | 0.050 |
Why?
|
Gadolinium | 1 | 2008 | 960 | 0.050 |
Why?
|
Papillomavirus Infections | 1 | 2015 | 1610 | 0.050 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2015 | 2019 | 0.050 |
Why?
|
Predictive Value of Tests | 2 | 2020 | 15262 | 0.050 |
Why?
|
Lung | 1 | 2020 | 9994 | 0.050 |
Why?
|
Technetium Tc 99m Aggregated Albumin | 1 | 2020 | 66 | 0.050 |
Why?
|
Colorectal Neoplasms | 1 | 2021 | 6901 | 0.050 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 4567 | 0.050 |
Why?
|
Retrospective Studies | 5 | 2024 | 80575 | 0.050 |
Why?
|
Liver Circulation | 1 | 2020 | 159 | 0.050 |
Why?
|
Corpus Callosum | 1 | 2005 | 751 | 0.040 |
Why?
|
Fibrosarcoma | 1 | 2002 | 308 | 0.040 |
Why?
|
Microwaves | 1 | 2021 | 185 | 0.040 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2006 | 1496 | 0.040 |
Why?
|
Retreatment | 1 | 2020 | 598 | 0.040 |
Why?
|
Carrier Proteins | 1 | 2011 | 4936 | 0.040 |
Why?
|
Pulmonary Circulation | 1 | 2020 | 743 | 0.040 |
Why?
|
Phantoms, Imaging | 1 | 2006 | 2524 | 0.040 |
Why?
|
Humans | 14 | 2024 | 761326 | 0.040 |
Why?
|
Time Factors | 4 | 2024 | 39974 | 0.030 |
Why?
|
Adult | 6 | 2024 | 221122 | 0.030 |
Why?
|
Microspheres | 1 | 2019 | 785 | 0.030 |
Why?
|
Female | 9 | 2024 | 392485 | 0.030 |
Why?
|
Male | 8 | 2024 | 360621 | 0.030 |
Why?
|
Collagen | 1 | 2002 | 2638 | 0.030 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2005 | 2790 | 0.030 |
Why?
|
Alphapapillomavirus | 1 | 2015 | 218 | 0.030 |
Why?
|
Radiation Dosage | 1 | 2020 | 1958 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2024 | 58946 | 0.020 |
Why?
|
Gastrin-Releasing Peptide | 1 | 2011 | 37 | 0.020 |
Why?
|
Middle Aged | 6 | 2024 | 220774 | 0.020 |
Why?
|
Polyethylene Glycols | 2 | 2007 | 1188 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2021 | 6473 | 0.020 |
Why?
|
Endovascular Procedures | 1 | 2024 | 2181 | 0.020 |
Why?
|
Recurrence | 1 | 2022 | 8470 | 0.020 |
Why?
|
Hematopoietic Stem Cells | 1 | 2002 | 3396 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2002 | 5114 | 0.020 |
Why?
|
Mice | 4 | 2011 | 81474 | 0.020 |
Why?
|
Aged | 4 | 2024 | 169179 | 0.020 |
Why?
|
Prostatic Neoplasms | 1 | 2011 | 11116 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2020 | 3687 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2019 | 5247 | 0.020 |
Why?
|
Micelles | 1 | 2007 | 192 | 0.020 |
Why?
|
Patient Selection | 1 | 2019 | 4244 | 0.020 |
Why?
|
Host-Pathogen Interactions | 1 | 2015 | 1457 | 0.020 |
Why?
|
Diagnostic Imaging | 1 | 2020 | 3531 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2015 | 14665 | 0.020 |
Why?
|
Animals | 5 | 2011 | 168388 | 0.020 |
Why?
|
Risk Factors | 2 | 2024 | 74152 | 0.020 |
Why?
|
Disability Evaluation | 1 | 2012 | 1836 | 0.020 |
Why?
|
Gadolinium DTPA | 1 | 2008 | 823 | 0.020 |
Why?
|
Surface Properties | 1 | 2007 | 1160 | 0.010 |
Why?
|
Phospholipids | 1 | 2007 | 786 | 0.010 |
Why?
|
Activities of Daily Living | 1 | 2012 | 2421 | 0.010 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2007 | 2498 | 0.010 |
Why?
|
Collagen Type XVIII | 1 | 2002 | 52 | 0.010 |
Why?
|
Monte Carlo Method | 1 | 2007 | 1257 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2015 | 5492 | 0.010 |
Why?
|
Anisotropy | 1 | 2005 | 1283 | 0.010 |
Why?
|
Endostatins | 1 | 2002 | 168 | 0.010 |
Why?
|
Magnetics | 1 | 2004 | 599 | 0.010 |
Why?
|
Kinetics | 1 | 2008 | 6374 | 0.010 |
Why?
|
Antibodies | 1 | 2008 | 2421 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2021 | 39108 | 0.010 |
Why?
|
Risk Assessment | 1 | 2020 | 23981 | 0.010 |
Why?
|
Pilot Projects | 1 | 2012 | 8632 | 0.010 |
Why?
|
Transduction, Genetic | 1 | 2002 | 901 | 0.010 |
Why?
|
Cattle | 1 | 2004 | 3849 | 0.010 |
Why?
|
Cohort Studies | 1 | 2021 | 41440 | 0.010 |
Why?
|
Neoplasm Transplantation | 1 | 2002 | 2014 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2015 | 8997 | 0.010 |
Why?
|
Models, Molecular | 1 | 2008 | 5439 | 0.010 |
Why?
|
Telemedicine | 1 | 2015 | 3041 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2015 | 20092 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2002 | 6128 | 0.010 |
Why?
|
Cornea | 1 | 2002 | 1332 | 0.010 |
Why?
|
Bone Marrow Transplantation | 1 | 2002 | 2693 | 0.010 |
Why?
|
Computer Simulation | 1 | 2007 | 6236 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2002 | 3734 | 0.010 |
Why?
|
Drug Delivery Systems | 1 | 2004 | 2223 | 0.010 |
Why?
|
Genetic Vectors | 1 | 2002 | 3393 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2005 | 7045 | 0.010 |
Why?
|
Peptides | 1 | 2004 | 4342 | 0.010 |
Why?
|
Angiogenesis Inhibitors | 1 | 2002 | 2047 | 0.010 |
Why?
|
United States | 1 | 2020 | 72317 | 0.010 |
Why?
|
Neovascularization, Pathologic | 1 | 2002 | 2644 | 0.010 |
Why?
|
Cell Line | 1 | 2004 | 15599 | 0.010 |
Why?
|
Prognosis | 1 | 2005 | 29588 | 0.000 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2002 | 5670 | 0.000 |
Why?
|
Mice, Inbred C57BL | 1 | 2002 | 22154 | 0.000 |
Why?
|
Pregnancy | 1 | 2005 | 29858 | 0.000 |
Why?
|
Lung Neoplasms | 1 | 2002 | 13333 | 0.000 |
Why?
|
Adolescent | 1 | 2005 | 88305 | 0.000 |
Why?
|
Concepts
(144)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(34)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_